日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Inhibition of lysine acetyltransferase KAT6 in ER+HER2- metastatic breast cancer: a phase 1 trial

ER+HER2 转移性乳腺癌中赖氨酸乙酰转移酶 KAT6 的抑制:一项 1 期试验

Toru Mukohara, Yeon Hee Park, David Sommerhalder, Kan Yonemori, Erika Hamilton, Sung-Bae Kim, Jee Hyun Kim, Hiroji Iwata, Toshinari Yamashita, Rachel M Layman, Monica Mita, Timothy Clay, Yee Soo Chae, Catherine Oakman, Fengting Yan, Gun Min Kim, Seock-Ah Im, Geoffrey J Lindeman, Hope S Rugo, Marlon

Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients

转移性乳腺癌患者血液中存在异质性非典型细胞群

Maryam B Lustberg, Priya Balasubramanian, Brandon Miller, Alejandra Garcia-Villa, Clayton Deighan, Yongqi Wu, Sarah Carothers, Michael Berger, Bhuvaneswari Ramaswamy, Erin R Macrae, Robert Wesolowski, Rachel M Layman, Ewa Mrozek, Xueliang Pan, Thomas A Summers, Charles L Shapiro, Jeffrey J Chalmers

Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors

γ分泌酶抑制剂联合多西他赛治疗人乳腺肿瘤的临床前及临床研究

Anne F Schott, Melissa D Landis, Gabriela Dontu, Kent A Griffith, Rachel M Layman, Ian Krop, Lacey A Paskett, Helen Wong, Lacey E Dobrolecki, Michael T Lewis, Amber M Froehlich, Jaya Paranilam, Daniel F Hayes, Max S Wicha, Jenny C Chang